Tags

Type your tag names separated by a space and hit enter

Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN).
J Crohns Colitis. 2012 Apr; 6(3):345-53.JC

Abstract

BACKGROUND AND AIMS

The use of complementary and alternative medicine (CAM) has been increasing in recent decades. Our aim was to determine the proportion of CAM use among patients with inflammatory bowel disease (IBD) in a longitudinal, population-based cohort and to identify predictive factors for CAM use.

METHODS

The Inflammatory Bowel South-Eastern Norway (IBSEN) study is a population-based IBD cohort that has been followed prospectively for 10 years. The ten-year follow-up was conducted from 2000 to 2004 and included a questionnaire regarding CAM, a structured interview, a review of hospital records, a clinical examination, laboratory tests, and an ileocolonoscopy.

RESULTS

Of the 620 patients evaluated at the ten-year follow-up, 517 (84%) completed the CAM questionnaire, 353 had ulcerative colitis (UC), 164 had Crohn's disease (CD), and 50% were male. Thirty percent reported the use of CAM at some point since their IBD diagnosis, and 7.5% reported current CAM use. More CD patients than UC patients reported CAM use (38% vs. 27%, respectively; p=0.01). Younger age, female gender, and higher education level predicted CAM use in UC, whereas younger age was the only predictor of CAM use in CD. Thirty-six percent of the CAM users were mostly satisfied or very satisfied with the treatment.

CONCLUSION

One third of the patients in this population-based cohort had used CAM at some point during a ten-year disease course, but only 7.5% reported current CAM use. CAM use was more common in the CD than in the UC patients. Only socio-demographic factors, such as age, gender and education, predicted CAM use.

Authors+Show Affiliations

Department of Gastroenterology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Norway. randi.opheim@medisin.uio.noNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

22405172

Citation

Opheim, Randi, et al. "Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease: the Results of a Population-based Inception Cohort Study (IBSEN)." Journal of Crohn's & Colitis, vol. 6, no. 3, 2012, pp. 345-53.
Opheim R, Hoivik ML, Solberg IC, et al. Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN). J Crohns Colitis. 2012;6(3):345-53.
Opheim, R., Hoivik, M. L., Solberg, I. C., & Moum, B. (2012). Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN). Journal of Crohn's & Colitis, 6(3), 345-53. https://doi.org/10.1016/j.crohns.2011.09.007
Opheim R, et al. Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease: the Results of a Population-based Inception Cohort Study (IBSEN). J Crohns Colitis. 2012;6(3):345-53. PubMed PMID: 22405172.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN). AU - Opheim,Randi, AU - Hoivik,Marte L, AU - Solberg,Inger C, AU - Moum,Bjorn, AU - ,, Y1 - 2011/10/13/ PY - 2011/08/25/received PY - 2011/09/14/revised PY - 2011/09/15/accepted PY - 2012/3/13/entrez PY - 2012/3/13/pubmed PY - 2012/7/26/medline SP - 345 EP - 53 JF - Journal of Crohn's & colitis JO - J Crohns Colitis VL - 6 IS - 3 N2 - BACKGROUND AND AIMS: The use of complementary and alternative medicine (CAM) has been increasing in recent decades. Our aim was to determine the proportion of CAM use among patients with inflammatory bowel disease (IBD) in a longitudinal, population-based cohort and to identify predictive factors for CAM use. METHODS: The Inflammatory Bowel South-Eastern Norway (IBSEN) study is a population-based IBD cohort that has been followed prospectively for 10 years. The ten-year follow-up was conducted from 2000 to 2004 and included a questionnaire regarding CAM, a structured interview, a review of hospital records, a clinical examination, laboratory tests, and an ileocolonoscopy. RESULTS: Of the 620 patients evaluated at the ten-year follow-up, 517 (84%) completed the CAM questionnaire, 353 had ulcerative colitis (UC), 164 had Crohn's disease (CD), and 50% were male. Thirty percent reported the use of CAM at some point since their IBD diagnosis, and 7.5% reported current CAM use. More CD patients than UC patients reported CAM use (38% vs. 27%, respectively; p=0.01). Younger age, female gender, and higher education level predicted CAM use in UC, whereas younger age was the only predictor of CAM use in CD. Thirty-six percent of the CAM users were mostly satisfied or very satisfied with the treatment. CONCLUSION: One third of the patients in this population-based cohort had used CAM at some point during a ten-year disease course, but only 7.5% reported current CAM use. CAM use was more common in the CD than in the UC patients. Only socio-demographic factors, such as age, gender and education, predicted CAM use. SN - 1876-4479 UR - https://www.unboundmedicine.com/medline/citation/22405172/Complementary_and_alternative_medicine_in_patients_with_inflammatory_bowel_disease:_the_results_of_a_population_based_inception_cohort_study__IBSEN__ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1873-9946(11)00257-1 DB - PRIME DP - Unbound Medicine ER -